ScanSource Inc. (NASDAQ:SCSC), a technology distributor known for complex technologies, recently closed its acquisition of MicroAge, a full-service solutions integrator with a 50-year legacy of enterprise support. This was an all-cash deal valued at $220.5 million, financed through ScanSource's existing credit facility.
ScanSource management expects the acquisition to be accretive to the company's gross profit margin, adjusted EBITDA margin and non-GAAP EPS in the first year following closing, while also being free-cash-flow positive. Beyond the numbers, the acquisition expands ScanSource's capabilities in higher-margin IT solutions and services, including cloud, cybersecurity, data center and AI.
This announcement follows the company's recent fiscal 2026 fourth quarter results. With figures of $953.1 million, ScanSource posted a 17.3% growth in net sales during the final quarter, compared to the same period last year. Its non-GAAP diluted EPS of $1.46 surged 43.1% during the reported period.
On the cautionary side, despite its strategic merits, the deal introduces meaningful risks. It leads to added leverage since the company is relying on borrowings to finance the acquisition. A higher debt burden could lower the company's financial flexibility in case the integration costs exceed expectations.
Another consideration is that management's expected margin, earnings, and free-cash-flow benefits remain projections rather than realized results. The eventual outcomes are likely to be affected by broader macroeconomic hurdles, customer churn, or fluctuations across the technology distribution market.
The latest quarterly figures also point to lingering uncertainty, since factors beyond the company's control, such as macroeconomic conditions, remain a genuine risk. Additionally, the Specialty Technology Solutions segment generated a gross margin of about 10.8% in fiscal 2026, underscoring the relatively limited margin buffer inherent in ScanSource's distribution business.
Institutional data tracked by Insider Monkey, covering more than 1,000 hedge funds, shows a slight uptick in exposure to the stock. According to 13F filing data, total number of hedge funds that were invested in ScanSource jumped to 20 by the end of second quarter in 2026, relative to 16 in the previous quarter. Short interest sits at 4.47%, which indicates modest level of betting against the stock.
With 3.84 million shares, BlackRock is the largest institutional investor owning 19.07% of the outstanding shares. Other notable institutional names include Vanguard Portfolio Management and Dimensional Fund Advisors, which held 8.51% and 8.15% of outstanding shares, respectively.
The MicroAge deal points to ScanSource's current drive to pursue growth opportunities through targeted acquisitions, which could strengthen its footing within the technology distribution and integration space but could create long-term shareholder value. It also widens the company's solutions integration capabilities by integrating MicroAge's long-standing channel expertise and full-service offerings.
While we acknowledge the potential of SCSC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 12 Best Industrial Stocks With More Than 50% Upside and 10 Best Stocks Under $10 That Could Triple.
Disclosure: None. Follow Insider Monkey on Google News.